A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka
- PMID: 25103467
- PMCID: PMC4138405
- DOI: 10.1186/1471-2458-14-817
A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka
Abstract
Background: Access to medicines is a universal right. Low availability and low affordability of medicines are issues that deny this right to a significant proportion of the world population. The objective of this study was to determine the availability, price and affordability of essential medicines prescribed to treat non communicable diseases in Sri Lanka.
Methods: Methodology was based on the 2nd edition of the World Health Organization Health Action International Manual. A country survey was conducted and facilities representing both public and private pharmacies were selected. A total of 109 facilities was surveyed. At each facility data on the availability and prices of 50 essential medicines for non communicable diseases were collected. Percentage availability, median price of originator brand and lowest priced generic, median price ratio to the International Reference Price were calculated for surveyed medicines. Affordability was determined using the daily incomes of the lowest--paid unskilled government worker.
Results: Semi government community pharmacies had the highest (>80%) availability while outdoor pharmacies of public health care facilities, private pharmacies and outdoor pharmacies of private hospital showed a fairly high availability (50 - 80%) of surveyed medicines.Unit price of 76% of selected individual medicines was less than ten Sri Lankan rupees. Out of these 28% of medicines cost less than one Sri Lanka rupee. For 21 of the surveyed medicines the median price ratio to the international reference price was less than one. The prices of originator brands for 14 surveyed medicines were more than five times that of the lowest price generics.Less than a single day's wages was adequate to purchase a month's supply of the lowest priced generic of more than 67% of surveyed medicines.
Conclusions: The availability of selected essential medicines was fairly high in both public and private sectors in Sri Lanka. Most medicines are affordable to the lowest income earners in the community. There were many generic brands and generics available for most of the medicines in private and semi government community pharmacies increasing both availability and affordability.
Figures




Similar articles
-
Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.PLoS One. 2017 Feb 7;12(2):e0171284. doi: 10.1371/journal.pone.0171284. eCollection 2017. PLoS One. 2017. PMID: 28170413 Free PMC article.
-
Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.PLoS One. 2019 Apr 25;14(4):e0216122. doi: 10.1371/journal.pone.0216122. eCollection 2019. PLoS One. 2019. PMID: 31022276 Free PMC article.
-
A comprehensive survey of cancer medicines prices, availability and affordability in Ghana.PLoS One. 2023 May 3;18(5):e0279817. doi: 10.1371/journal.pone.0279817. eCollection 2023. PLoS One. 2023. PMID: 37134123 Free PMC article.
-
Health System Capacity and Access Barriers to Diagnosis and Treatment of CVD and Diabetes in Nepal.Glob Heart. 2021 May 18;16(1):38. doi: 10.5334/gh.927. Glob Heart. 2021. PMID: 34040951 Free PMC article.
-
High medicine prices and poor affordability.Curr Opin Psychiatry. 2011 Jul;24(4):341-5. doi: 10.1097/YCO.0b013e3283477b68. Curr Opin Psychiatry. 2011. PMID: 21532479 Review.
Cited by
-
A comparative systematic review of risk factors, prevalence, and challenges contributing to non-communicable diseases in South Asia, Africa, and Caribbeans.J Health Popul Nutr. 2024 Sep 9;43(1):140. doi: 10.1186/s41043-024-00607-2. J Health Popul Nutr. 2024. PMID: 39252085 Free PMC article.
-
Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon.BMC Health Serv Res. 2019 Dec 18;19(1):973. doi: 10.1186/s12913-019-4828-0. BMC Health Serv Res. 2019. PMID: 31852546 Free PMC article.
-
Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia.PLoS One. 2019 Dec 13;14(12):e0226169. doi: 10.1371/journal.pone.0226169. eCollection 2019. PLoS One. 2019. PMID: 31834889 Free PMC article.
-
Availability and affordability of antidiabetic medicines in Herat of Afghanistan in 2023.J Diabetes Metab Disord. 2024 Jun 14;23(2):1929-1940. doi: 10.1007/s40200-024-01444-0. eCollection 2024 Dec. J Diabetes Metab Disord. 2024. PMID: 39610474 Free PMC article.
-
Availability, prices and affordability of selected essential medicines in Jordan: a national survey.BMC Health Serv Res. 2018 Oct 19;18(1):787. doi: 10.1186/s12913-018-3593-9. BMC Health Serv Res. 2018. PMID: 30340486 Free PMC article.
References
-
- United Nations Publication . Indicators for Monitoring the Millennium Development Goals. 2003.
-
- World Health Organization . WHO medicines strategy. Geneva, Switzerland: Countries at the core 2004-2007; 2004.
-
- Ministry of Health . National list of Essential medicines Sri Lanka: 5th Revision, 2013–2014. 2013.
-
- WHO/HAI . Measuring medicine prices, availability, affordability and price components. 2 2008.
-
- World Health Organization . Preventing chronic disease: a vital investment. 2005.
Pre-publication history
-
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/14/817/prepub
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources